MCI Multispecialty Grand Rounds: Updates in the Management of Metastatic Triple Negative Breast Cancer
Triple-negative breast cancer (TNBC) is associated with a high risk of recurrence and generally a bad prognosis. More than one-third of patients with TNBC will present distant metastases during the course of their disease.
During this conference Dr. Traina will discuss checkpoint inhibition in metastatic TNBC. Participants will also discover novel therapies in development for metastatic TNBC.
|Live- MCI – Tumor Board Room - 3N110|
Oncologists, Radiation Oncologists, Hematology Oncologists, Radiation Therapists, General Surgeons, General Practitioners, Obstetrics and Gynecologists, Oncologists, Radiation Oncologists, Nurses, Social Workers, Patient Navigators and all other interested healthcare professionals.
- Identify relevant targets in TNBC.
- Implement checkpoint inhibition in metastatic TNBC.
- Accurately assess novel therapies in development for metastatic TNBC.
Tiffany A. Traina, MD
Vice Chair, Oncology Operations; Dept of Medicine
Clinical Director, Breast Medicine Service
Section Head, Triple Negative Breast Cancer Clinical Research Program
Tiffany A. Triana, M.D., indicated that she is a consultant for Genentech/Roche, AstraZeneca, Merck, Puma Biotechnology, Novartis, Innocrin Pharma, Astellas Pharma, Immunomedics, Daiichi Sankyo and Carrick Pharm, and she will not include off-label or unapproved product usage in her presentation(s) or discussion(s).
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have relevant financial relationships to disclose.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 1 credit hour, CE Broker Course #20-680158, by the Florida Boards of Medicine and Osteopathic Medicine and by the Florida Council of Physician Assistants.
This activity has also been approved for 1 credit hour for Nursing, Nurse Practitioners, and Clinical Chaplains. Baptist Health South Florida CE Broker Provider #50-182.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
NOTE: Due to limited space, this conference is open to Baptist Health affiliated Medical Staff and Clinical Employees.
Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.